financetom
Business
financetom
/
Business
/
LifeMD Files for $150 Million Mixed Shelf
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
LifeMD Files for $150 Million Mixed Shelf
Jun 7, 2024 10:27 AM

01:00 PM EDT, 06/07/2024 (MT Newswires) -- LifeMD ( LFMD ) filed a registration statement Friday with the Securities and Exchange Commission covering the potential sale of up to $150 million of securities from time to time.

The securities include common stock, preferred stock, debt securities, warrants and units.

The company expects to use proceeds for operations and general corporate purposes, including capital expenditures, general working capital and possible future acquisitions.

Price: 8.02, Change: +0.07, Percent Change: +0.88

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Polestar Gets $450 Million Term Loan, Renews $499 Million Green Trade Finance Facility
Polestar Gets $450 Million Term Loan, Renews $499 Million Green Trade Finance Facility
Feb 28, 2025
07:28 AM EST, 02/28/2025 (MT Newswires) -- Polestar (PSNY) said Friday it obtained a 12-month term facility of up to $450 million and renewed its 480 million euro ($499.3 million) green trade finance facility. The new term facility follows over $800 million in 12-month term facilities secured in December, the company said. Polestar said it first entered into a 12-month...
Regeneron Says Linvoseltamab Recommended for EU Approval to Treat Multiple Myeloma
Regeneron Says Linvoseltamab Recommended for EU Approval to Treat Multiple Myeloma
Feb 28, 2025
07:40 AM EST, 02/28/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said Friday that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended a conditional marketing authorization for linvoseltamab to treat adults with relapsed and refractory multiple myeloma. The company said the recommendation specifically covers patients who have received at least three prior...
Docebo Q4 Results Beat Estimates, but Q1 Revenue Outlook Is Lower Than Expected
Docebo Q4 Results Beat Estimates, but Q1 Revenue Outlook Is Lower Than Expected
Feb 28, 2025
07:36 AM EST, 02/28/2025 (MT Newswires) -- Docebo ( DCBO ) , a learning platform provider, on Friday reported a beat in adjusted profit and revenue for the fourth quarter, while also providing a lower-than-expected revenue outlook for the first quarter of 2025. The company reported adjusted net income of US$8.7 million for the three months ended Dec. 31, compared...
CompoSecure Completes Spin-Off of Resolute Holdings Into Separate Public Company
CompoSecure Completes Spin-Off of Resolute Holdings Into Separate Public Company
Feb 28, 2025
07:32 AM EST, 02/28/2025 (MT Newswires) -- CompoSecure ( CMPO ) said Friday it completed the spin-off of its subsidiary, Resolute Holdings Management (RHLD), into an independent public company. As part of the separation, the company said its shareholders received one share of Resolute Holdings for every 12 shares of CompoSecure ( CMPO ) common stock held as of February...
Copyright 2023-2026 - www.financetom.com All Rights Reserved